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modules into a preexisting PKS multienzyme assembly
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1Cambridge Centre for Molecular Recognition and between two other extension modules [14]. However,
Department of Biochemistry the hybrid PKSs so far produced by this approach have
University of Cambridge been poor yielding compared to their parent synthases,
80 Tennis Court Road largely because they continue to produce polyketides
Cambridge CB2 1GA that are the result of chain extension and processing
United Kingdom by the native PKS modules, the interpolated module of
2 Cambridge Centre for Molecular Recognition and enzyme activities apparently being ignored. This phe-
University Chemical Laboratory nomenon has been termed “skipping” [14].
University of Cambridge Here, we report the results of experiments designed to
Lensfield Road investigate the molecular basis of skipping. In particular,
Cambridge CB2 1EW we wished to determine whether the domains of the
United Kingdom interpolated module play an active role in the process
that gives rise to the skipped product and whether it is
required to aid the channeling of enzyme-bound polyke-
Summary tide chains between the native modules that flank it in
the hybrid PKS. The model system we chose was the
A tetraketide synthase containing a loading module (LM), tetraketide synthase Ery1-Rap2-Ery2-TE, whose con-
the extension modules erythromycin module 1, rapa- struction has been previously described [14] and which
mycin module 2, and erythromycin module 2 (LM-Ery1- contains rapamycin PKS module 2 [15, 16] inserted be-
Rap2-Ery2-TE), when expressed in Saccharopolyspora tween erythromycin modules 1 and 2 in the truncated
erythraea strain JC2, produced as previously reported PKS DEBS1-TE ([17]; Figure 1). The major products of
a mixture of tetraketide lactones (minor products) and this synthase are the triketide lactones 1 and 2 (Figure
triketide lactones (major products). Several alternative 1) with tetraketide 3 as a minor product. The tetraketide
plausible mechanisms by which this “skipping” phe- synthase and mutant versions of it are conveniently ex-
nomenon might occur may be proposed. Site-directed pressed in S. erythraea JC2 (a strain from which the
mutagenesis of the ketosynthase (KS) and acylcarrier native erythromycin PKS [DEBS] genes have been al-
protein (ACP) domains in the interpolated module has most wholly deleted) [17].
shown that skipping within the hybrid PKS involves We initially considered four alternative mechanisms
passage of the growing polyketide through the inter- (Figure 2) by which skipping might occur within Ery1-
polated module, by direct ACP-to-ACP transfer of the Rap2-Ery2-TE. These mechanisms can be distinguished
polyketide chain. through the differing predictions that they make about
the involvement in the process of skipping of the keto-
Introduction synthase (KS) and acylcarrier protein (ACP) active sites
within Rap2.
Complex polyketides are a large and structurally diverse Mechanism 1: KS(Rap2) to ACP(Rap2)
class of natural products that include many compounds In this mechanism, the diketide chain is passed as ex-
possessing antibiotic or other clinically useful proper- pected from ACP(Ery1) to KS(Rap2) and then transferred
ties. They are produced by stepwise chain assembly on without chain extension to ACP(Rap2) in a trans-thioes-
a modular polyketide synthase (PKS). Such PKSs are terification that requires that ACP(Rap2) be unprimed
giant multienzymes containing a different set or “mod- with a chain extension malonyl group. Once the polyke-
ule” of enzyme domains to accomplish each successive tide chain is transferred to the 4-phosphopantetheinyl
cycle of polyketide chain extension [1, 2]. The evident prosthetic group of ACP(Rap2), extension is no longer
modularity of these systems, along with numerous re-
possible within Rap2, and the chain can be passed di-
ports that productive hybrid polyketide synthases may
rectly to KS(Ery2). Consequently, KS(Ery2) is loaded with
be engineered by swapping either one [3–6] or more
the diketide with which it is normally presented in its
[7–13] domains or modules between different natural
native environment. The active sites of KS(Rap2) andPKSs, has generated increasing interest in the degree
ACP(Rap2) are both required for skipping to occur.to which this modularity might be exploited to make
Mechanism 2: ACP(Ery1) to ACP(Rap2)large numbers of new, potentially valuable natural prod-
Here, the diketide chain at ACP(Ery1) is passed directlyucts. Another recent approach, which greatly extends
to ACP(Rap2) by trans-thioesterification. The phospho-
pantetheinyl arms of ACP domains in adjacent modules
3 Correspondence: pfl10@mole.bio.cam.ac.uk both interact with the same intervening KS active site
4 Present address: Biotica Technology Ltd., 181A Huntingdon Road,
to effect normal chain extensions. It is therefore possibleCambridge CB3 0DJ, United Kingdom.
that these same groups are able to become close5 Present address: Max Planck Institut fu¨r Biochemie, Am Klopfer-
spitz 18a, D-82152 Martinsried, Munich, Germany. enough for the growing chain to be passed directly from
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Figure 1. The Lactone Products Produced by the Truncated Model PKS DEBS1-TE and by the Tetraketide Synthase LM-Ery1-Rap2-Ery2-TE
(A) The lactone products produced by the truncated model PKS DEBS1-TE.
(B) Those products produced by the tetraketide synthase LM-Ery1-Rap2-Ery2-TE.
Abbreviations are as follows: LM, loading module; KS, ketosynthase; AT, acyltransferase; KR, ketoreductase; ACP, acylcarrier protein; and
TE, thioesterase/cyclase.
ACP(Ery1) to ACP(Rap2). Only the ACP(Rap2) active site is mutated to alanine in the ketosynthase domain. This
module was introduced into the interdomain regionis utilized and not the KS(Rap2) active site.
Mechanism 3: KS(Rap2) to KS(Ery2) N-terminal to the KS2 in DEBS1TE to yield the tetraketide
synthase LM-Ery1-Rap2(KS)-Ery2-TE. The resultingHere, the diketide chain at KS(Rap2) is passed directly to
KS(Ery2) by trans-thioesterification. Although this direct plasmid, pIPT62, contains the tetraketide synthase ex-
pressed from the actI promoter, under the control oftransfer is a formal possibility, current models of modu-
lar PKS structure [18, 19] suggest that it is unlikely. Only actII-ORF4 in pCJR24 [14].
the KS(Rap2) is utilized and not the ACP(Rap2).
Mechanism 4: ACP(Ery1) to KS(Ery2)
The polyketide chain might also be transferred directly Construction of the Tetraketide Synthase
LM-Ery1-Rap2(ACP)-Ery2-TE, in which(or via a carrier molecule such as coenzyme A) from
ACP(Ery1) to KS(Ery2), and the activities of the Rap2 the Active Site Serine Residue of the Rapamycin
ACP2 Is Mutated to Alaninemodule are not required at all. Again, from current mod-
els [18, 19] it seems likely that for the prosthetic group A similar cloning procedure was used to introduce a
mutation at the rapamycin module 2 ACP. The mutationof ACP(Ery1) to transfer a polyketide moiety directly
to KS(Ery2), (hitherto unsuspected) structural flexibility encoded for a change from serine to alanine. The mutant
rapamycin module 2 ACP was cloned into DEBS1TE,would be required within these modular PKSs.
Site-directed mutagenesis was used to knock out es- N-terminal to KS2. pIPT63 contains the tetraketide syn-
thase LM-Ery1-Rap2(ACP)-Ery2-TE under the actI pro-sential residues in either one or both of the KS(Rap2)
and ACP(Rap2) active sites in LM-Ery1-Rap2-Ery2-TE, moter.
and the effect of these mutations on triketide and tetra-
ketide production in recombinant S. erythraea was then
monitored. Construction of the Tetraketide Synthase
LM-Ery1-Rap2(KS/ACP)-Ery2-TE, in which
the Active Site residues of Rapamycin KS2Results and Discussion
and ACP2 Are Both Mutated to Alanine
The two mutations described above were combined toConstruction of the Tetraketide Synthase
LM-Ery1-Rap2(KS)-Ery2-TE, in which make a doubly mutated rapamycin module 2 (KS/ACP).
This module was cloned into DEBS1TE, N-terminal tothe Active Site Cysteine Residue of Rapamycin
KS2 Is Mutated to Alanine KS2. pIPT64 contains the tetraketide synthase LM-Ery1-
Rap2(KS/ACP)-Ery2-TE, expressed under the actI pro-Standard cloning protocols were used to make a version
of rapamycin module 2 in which the active site cysteine moter.
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Module Insertion Yields Full-Length Polyketide
Products of the Predicted Structure and a Triketide
Lactone by a Pathway in which the Inserted Rap2
Module Is Skipped
The tetraketide synthase LM-Ery1-Rap2-Ery2-TE syn-
thesizes both the tetraketide lactone 3 and the triketide
lactones 1 and 2, and the triketide:tetraketide ratio is
approximately 20:1, confirming previous observations
[14]. Rapamycin module 2 selects an acetate extension
unit and gives rise to a stereochemistry at the hydroxyl
functionality that is opposite to that produced by ery
module 2 [15, 16]. The structure of 3 is that predicted
by the sequential action of erythromycin module 1, rapa-
mycin module 2, and erythromycin module 2. As pre-
viously noted [14], the exclusive incorporation of propio-
nate chain extension units in the triketide lactones 1 and
2, and the stereochemistry at C4 in these products,
demonstrates conclusively that formation of 1 and 2 did
not involve the AT or KR enzymatic activities of the
interpolated rapamycin module 2.
Skipping Mechanism in LM-Ery1-Rap2-Ery2-TE
Involves Active Sites within Rap2
The lack of tri- and tetraketide lactone production by
LM-Ery1-Rap2(ACP)-Ery2-TE or LM-Ery1-Rap2(KS/
ACP)-Ery2-TE and the contrasting production of trike-
tide lactones by LM-Ery1-Rap2-Ery2-TE (control) and
LM-Ery1-Rap2(KS)-Ery2-TE demonstrate clearly that
the interpolated Rap2 module actively participates inFigure 2. Alternative Proposed Mechanisms for Skipping of an In-
the skipping of the polyketide chain from Ery1 to Ery2.terpolated Module in a Hybrid Polyketide Synthase
Mechanism 4 (Figure 2) can therefore be safely dis-In mechanism 1, the polyketide chain is passed between modules
Ery1 and Ery2 via the KS and ACP active sites of the inserted Rap2 carded. It might have been argued that alternative fac-
module; in mechanism 2, the chain is passed via the Rap2 ACP tors, such as an effect of the point mutation(s) on expres-
active site only; in mechanism 3, the chain is passed via the Rap2 sion levels or the proper folding to a functional dimer,
KS active site only; and in mechanism 4, the chain is passed between underlie the inactivity of LM-Ery1-Rap2(ACP)-Ery2-TEmodules Ery1 and Ery2 without any involvement of the Rap2 KS
and LM-Ery1-Rap2(KS/ACP)-Ery2-TE. However, the re-and ACP active sites (perhaps via a carrier molecule). The inserted
sults from recent work on DEBS1-TE [20] strongly implyRap2 module is shown in red.
that these particular point mutations do not affect ex-
pression or folding. Mechanism 3 (Figure 2) can also be
discarded because it predicts that LM-Ery1-Rap2(KS)-Analysis of the Tri- and Tetraketide Products
Ery2-TE would be inactive in triketide production. WeProduced by Expression of pCJR54, pIPT62,
are left with mechanisms 1 and 2 (Figure 2), in each ofpIPT63, and pIPT64 in S. erythraea JC2
which the interpolated module must possess an activeGC-MS analysis of extracts of fermentation broths re-
ACP. Because the levels of triketide production fromvealed that the control strain S. erythraea JC2/pCJR54
LM-Ery1-Rap2(KS)-Ery2-TE were the same as those(LM-Ery1-Rap2-Ery2-TE) produced about 10 mg/liter of
from the control strain LM-Ery1-Rap2-Ery2-TE, withintriketide lactones 1 and 2, with the molar ratio of triketide
experimental error, it appears that if mechanism 1 does2:triketide 1 (as judged by GC analysis) being approxi-
operate, its contribution is rather small, and the majormately 10:1, together with about 0.5–1.0 mg/liter of tetra-
or sole pathway for skipping is revealed to be an AC-ketide lactone 3 (Figure 3). This is in agreement with
P(Ery1)-to-ACP(Rap2) chain transfer process (mecha-previously published findings [14]. SDS-polyacrylamide
nism 2).gel electrophoresis of extracts of this strain revealed
the presence of polypeptides of a subunit molecular
mass consistent with the proposed tetraketide synthase Skipping Requires that the ACP of the Interpolated
(C.J.M., unpublished data). The strain containing pIPT63 Module Not Be Primed with an Extender Unit
[LM-Ery1-Rap2(KS)-Ery2-TE] produced triketide lac- A skipping process that involves ACP-to-ACP chain
tones 1 and 2 in quantities similar to those produced transfer (mechanism 2) requires that the ACP of the
by the control strain (total 10 mg/liter, molar ratio 2:1 of skipped module must be free and not primed with an
10:1), but no tetraketide. The strain that contained extender malonyl group. The priming of an ACP domain
pIPT62 [LM-Ery1-Rap2(ACP)-Ery2-TE] and the strain is normally accomplished by the acyltransferase (AT)
that contained pIPT64 [LM-Ery1-Rap2(KS/ACP)-Ery2- domain within the module [21]. Three alternative plausi-
TE] yielded neither the tetraketide lactone nor the trike- ble mechanisms by which an ACP domain might become
unprimed are (1) the priming of an ACP domain by thetide lactones 1 and 2 (Figure 3).
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Figure 3. The Lactone Products Produced
by Mutagenized Versions of the Tetraketide
Synthase LM-Ery1-Rap2-Ery2-TE
A cross indicates the replacement of a single
essential active site residue within a Rap2
domain.
action of the AT domain may itself be reversed; (2) the Skipping by mechanism 2 might also be enhanced if
the rate of polyketide chain transfer from ACP(Ery1) tohydrolysis of the malonyl extender unit [22, 23]; and (3)
KS(Rap2) of the interpolated module is slowed signifi-adventitious decarboxylation of an ACP bound malonyl
cantly with respect to the rate of formation of unprimedgroup [24] to give an ACP bound acetyl group may be
ACP and the transfer to it of unextended chain. A slowerfollowed by hydrolysis of this group by the discrete thio-
rate of ACP(Ery1)-to-KS(Rap2) transfer compared withesterase TEII [25]. These effects will certainly be rein-
ACP-to-KS transfer between normally adjacent modulesforced if the AT domain of the interpolated module is not
would be consistent with poorer substrate recognitionfunctioning optimally, perhaps because of unfavorable
by a heterologous KS domain and would be in accordprotein-protein contacts within the hybrid PKS.
with recently published results [12] that suggest that
maintaining native ACP-KS interactions is important inThe Role of KS-Mediated Chain Transfers
the design of functional hybrid PKSs.Although not directly implicated in skipping, KS(Rap2)
could play an important role in facilitating ACP-to-ACP
Evolution of Modular PKS Functionpolyketide chain transfer. For effective chain transfer to
The evolution of modular polyketide synthases has pre-occur, the thiols of the two 4-phosphopantetheinyl
sumably come about by gene and hence module dupli-arms of ACP(Rap2) and ACP(Ery1) must come together
cation. However, extensive work on hybrid polyketideto allow trans-thioesterification. A KS active site recog-
synthases, reviewed for example by Staunton andnizes the prosthetic groups of both the preceding and
Weissman [21], clearly shows that mixing, matching, andfollowing ACPs, and it might be able to dock both these
inactivation of domains and modules frequently yieldsunits simultaneously. If so, the thioester group of the
inefficient synthases and may result in the abolition ofpolyketide-bearing prosthetic group and the thiol termi-
polyketide production. Such obstacles to effective po-nus of the following 4-phosphopantetheinyl unit will
lyketide synthesis are likely to arise within a polyketidenaturally be brought into proximity. It is plausible that
synthase after most evolutionary changes. This wouldan intervening inactive or retarded KS(Rap2) will also
act as a barrier to further evolution. Skipping would allowbe able to mediate such transfers (Figure 4).
any new duplicated modules to be bypassed on most
occasions and would ensure production of the original
polyketide metabolite for which there is existing selec-
tive pressure. However, it would also allow the intermit-
tent production of alternative novel product(s). If such
products confer an evolutionary advantage, then further
mutation will select for the relative levels of production.
On this model, the skipping process therefore makes
viable the required intermediates in the evolutionary pro-
cess. There has been no deliberate search for such
truncated products but, in addition to the well-known
example of the Streptomyces venezuelae pikromycin
PKS, which synthesizes both a pentaketide and a hex-
aketide (see below) [26], other reports have described
the presence of polyketide metabolites whose struc-
Figure 4. A Model for ACP(Ery1)-to-ACP(Rap2) Transfer Mediated
tures show that they may have arisen by skipping on aby the Intervening KS(Rap2) Domain
natural modular polyketide synthase [27]. The converseThe polyketide acyl chain (represented by R-CH2-CO-) can be trans-
situation, aberrant repeated use of an extension moduleferred to the 4-phosphopantetheine “swinging arm” ACP(Rap2)
(“stuttering”) within a modular PKS, has also been seenwithin the KS(Rap2) site, even when the active site cysteine residue
is replaced by alanine. at low level on a natural modular PKS [28, 29].
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described. S. erythraea strains were routinely maintained on R2T20Pikromycin
agar plates [36] and TSB medium (Difco) for liquid cultures at 30C.The pikromycin polyketide synthase from Streptomyces
After approximately 2 weeks on R2T20 agar at 30C, spores werevenezuelae contains six extension modules distributed
harvested and stored in 10% glycerol at 80C. TSB and SM3 ex-
between four multienzyme polypeptides PikAI–PikAIV pression media have been described elsewhere [37].
and is responsible for the production of both the 14-
membered macrocycle narbonolide and the 12-mem- Plasmids and DNA Manipulation Procedures
Construction of Plasmid pIPT62 Containing the Hybridbered macrocycle 10-deoxymethynolide [26]. The latter
Tetraketide Synthase LM-Ery1-Rap2(KS)-Ery2-TEcompound is the result of chain extension and pro-
DNA encoding parts of the rapamycin module 2 KS domain werecessing by the first five modules of the pikromycin
cloned between each of the EcoRI and BlpI sites that flank the KS
polyketide synthase and represents in formal terms a active site cysteine residue and an AflIII site introduced over the
natural example of a skipping process. It has been active site with concomitant mutation of the cysteine codon to an
alanine codon as follows. A 245 bp fragment encoding the N-ter-shown that the premature termination of the polyketide
minal region up to the mutated active site was amplified by PCRsynthase is achieved via a wholly novel mechanism, the
with the oligonucleotides 5-ATGATTACGAATTCGAGCTCGGTA-3production of an N-terminally truncated form of PikAIV
(reverse) and 5-TGGACGCGTTGACTGCGGTGGAACTACGGAA-3(housing module 6), and it has been proposed that this (forward). A 459 bp fragment encoding the C-terminal region up to
allows the pikromycin chain-terminating thioesterase the mutated active site was amplified by PCR with the oligonucleo-
(TE) to dock directly onto the ACP of module 5 rather tides 5-AGTCAACGCGTCCACACCCAGATCCCTGAA-3 (reverse)
and 5-GGACGCGCTGGCTGAGCAGCGTCACGCTGA-3 (forward)than after module 6 [30, 31]. However, skipping mecha-
(restriction sites shown in italics); each of these fragments wasnisms analogous to those described here, through
cloned into dephosphorylated SmaI-cut pUC18 (where the DNA se-which the pentaketide chain traverses the module 6
quences were confirmed by sequencing). The EcoRI-AflIII and AflIII-
within the truncated PikAIV to reach the C-terminal thio- BlpI fragments and EcoRI-BlpI-cut pCJR53 were assembled by liga-
esterase domain, are also possible. Indeed, such mech- tion to give the plasmid pIPT59, which contained the DNA encoding
anisms are under active investigation (D.H. Sherman, the rapamycin module 2 with a mutation at the KS active site. A
pIPT59 Sse8387I fragment housing the mutated rapamycin modulepersonal communication).
2 was cloned into pIB103 that had previously been linearized with
the same enzyme and dephosphorylated. The plasmid pIPT62 that
Significance contained the correctly oriented Sse8387I fragment was identified
by restriction analysis.
Construction of Plasmid pIPT63 Containing the HybridModular polyketide synthases are responsible for the
LM-Ery1-Rap2(ACP)-Ery2-TEbiosynthesis of a wide range of clinically important
DNA encoding parts of the rapamycin module 2 ACP domain werenatural products. The modular nature of the polyketide
cloned between the MluI and XbaI sites that flank the ACP activesynthases has made them attractive targets for use site serine residue and a PvuII site introduced over the active site
in the synthesis of new related bioactive compounds with concomitant mutation of the serine codon to an alanine codon
and for eventual use in combinatorial biosynthesis. as follows. A 1567 bp fragment encoding the N-terminal region up
to the mutated active site was amplified by PCR with the oligonucle-Polyketide synthases have been the recipients of many
otides 5-ATACGGGCGGAATGGAACGCGTGACT-3 (reverse) andmodifications, including even the interpolation of an
5-TTCACGGTCGACACAGCTGCTTCGTCGTCGTT-3 (forward). A 504entire heterologous PKS module into the erythromycin
bp fragment encoding the C-terminal region up to the mutated active
PKS and the model DEBS1-TE system. This system site was amplified by PCR with the oligonucleotides 5-ACGAC
yields the predicted extended polyketide chains but is GAAGCAGCTGTGTCGACCGTGAA-3 (reverse) and 5-TCGACTC
limited by the propensity of the hybrid PKS to ignore TAGAGGATCCCCGTATGGCCT-3 (forward) (restriction sites shown
in italics); each of these fragments was cloned into dephosphory-the presence of the inserted module, i.e., the module
lated SmaI-cut pUC18 (where the DNA sequences were confirmedis skipped. We have shown here that the interpolated
by sequencing). The MluI-PvuII and PvuII-XbaI fragments and MluI-module, and specifically the active site of the ACP
XbaI-cut pCJR53 were assembled by ligation to give the plasmid
domain, is required for skipping to occur. We propose pIPT60, which contained the DNA encoding the rapamycin module
that a major (if not the sole) pathway for skipping 2 with the ACP active site mutated from serine to alanine. A pIPT60
Sse8387I fragment housing the mutated rapamycin module 2 wasinvolves direct ACP-to-ACP chain transfer and note
cloned into pIB103 that had previously been linearized with thethat the phenomenon of skipping may have relevance
same enzyme and dephosphorylated. The plasmid pIPT63 that con-for natural modular polyketide synthases and for their
tained the correctly oriented Sse8387I fragment was identified by
evolution. restriction analysis.
Construction of Plasmid pIPT64 Containing the Hybrid
Experimental Procedures Tetraketide Synthase LM-Ery1-Rap2(KS/ACP)-Ery2-TE
DNA encoding part of rapamycin module 2 KS including the mutated
Chemical Analysis sequence at the active site was excised as an EcoRI-BlpI fragment
Gas chromatography mass spectrometry (GC-MS) was performed from pIPT59 and cloned into pIPT60 that had been cut with these
on a Finnigan MAT GCQ instrument. Analytical and preparative re- enzymes to give plasmid pIPT61. A pIPT61 Sse8387I fragment hous-
verse-phase high-performance liquid chromatography mass spec- ing the mutated rapamycin module 2 in which both KS and ACP
trometry (HPLC-MS) analyses were carried out on a Finnigan MAT active site sequences had been mutated was cloned into pIB103
LCQ instrument, with either an ES or API-MS interface and switching that had been linearized with the same enzyme and dephosphory-
between positive and negative ion modes as required. lated. The plasmid pIPT64 that contained the correctly oriented
Sse8387I fragment was identified.
Bacterial Strains and Culture Conditions Construction of S. erythraea Strains Housing pCJR54,
Escherichia coli DH10B (GibcoBRL) was used in all standard cloning pIPT62, pIPT63, or pIPT64
procedures and was grown in 2 TY medium [32]. Electrocompetent Protoplasts of S. erythraea NRRL2338 JC2 were transformed with
cells of DH10B were made as described previously [33]. Saccharo- pCJR54, pIPT62, pIPT63, or pIPT64 by adaptation [37] of a published
polyspora erythraea NRRL2338 (red variant) [34] was the kind gift procedure [36]. Transformants were selected on solid medium by
overlaying with thiostrepton (25 mg/l) after 24 hr.of Dr J.M. Weber. S. erythraea mutant strain JC2 [35] has been
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Growth and Extraction a recombinant Saccharopolyspora erythraea strain NRRL 2338
pIG1. I. Fermentation, isolation and biological activity. J. Anti-Aliquots (10 ml) of TSB media containing thiostrepton (5g/ml) were
inoculated with mycelia from a single transformant colony of S. biot. 51, 1029–1034.
10. McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Bet-erythraea NRRL2338 JC2:pCJR54, pIPT62, pIPT63, or pIPT64, and
the culture was incubated for 2–4 days. Plates of SM3 agar con- lach, M., and Ashley, G. (1999). Multiple genetic modifications
of the erythromycin polyketide synthase to produce a library oftaining thiostrepton (50 g/ml) were individually inoculated with 500
l from one of the liquid cultures and incubated for 10–14 days. novel “unnatural” natural products. Proc. Natl. Acad. Sci. USA
96, 1846–1851.Regions of approximately 1 cm2 were excised from each plate,
extracted with 1.2 ml ethyl acetate containing 2% formic acid at 11. Gokhale, R.S., Tsuji, S.Y., Cane, D.E., and Khosla, C. (1999).
Dissecting and exploiting intermodular communication in poly-50C for 15 min, and vortexed at room temperature for 30 min, and
the supernatant was removed. The solvent was removed in vacuo, ketide synthases. Science 284, 482–485.
12. Ranganathan, A., Timoney, M., Bycroft, M., Corte´s, J., Thomas,and the sample was dissolved in 50 l ethyl acetate.
I.P., Wilkinson, B., Kellenberger, L., Hanefeld, U., Galloway, I.S.,
Staunton, J., et al. (1999). Knowledge-based design of bimodu-Analysis of Culture Extracts
lar and trimodular polyketide synthases based on domain andThe ethyl acetate extracts were analyzed for tri- and tetraketide
module swaps: a route to simple statin analogues. Chem. Biol.lactones by GC-MS as previously described [12, 14]. Triketide lac-
6, 731–741.tones 1 and 2 and tetraketide lactone 3 were identified by compari-
13. Tang, L., Fu, H., and McDaniel, R. (2000). Formation of functionalson with traces for authentic samples of these compounds. Extracts
heterologous complexes using subunits from the picromycin,from nine different transformants of each strain were analyzed and
erythromycin and oleandomycin polyketide synthases. Chem.found to give comparable results.
Biol. 7, 77–84.
14. Rowe, C.J., Bo¨hm, I.U., Wilkinson, B., Rudd, B.A.M., Foster,Acknowledgments
G., Blackaby, A.P., Sidebottom, P.J., Roddis, Y., Buss, A.D.,
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